Cover image of the article: Evaluation of the clearance characteristics of liposomes in the human nose by gamma-scintigraphy

Image Credit:Iran J Pharm Res

Evaluation of the clearance characteristics of liposomes in the human nose by gamma-scintigraphy

Authors

Mahmoud Reza Jaafari1, 2,*, Mohsen Tafaghodi1, 3, Sayyed Abolghassem Sajadi Tabassi1, 3
1School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
2Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
3Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
*Corresponding Author: School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Email:m-jaafari@mums.ac.ir

Iranian Journal of Pharmaceutical Research:Vol. 4, issue 1; 3-11
Published online:Nov 20, 2010
Article type:Research Article
Received:Jul 01, 2004
Accepted:Aug 01, 2005
How to Cite:Jaafari MR, Tafaghodi M, Sajadi Tabassi SA. Evaluation of the clearance characteristics of liposomes in the human nose by gamma-scintigraphy. Iran J Pharm Res. 2022;4(1):e128220. doi: https://doi.org/10.22037/ijpr.2010.610

Abstract

The nasal cavity possesses many advantages as a site for drug delivery, such as, ease of administration, applicability for long term treatments and a large surface area for absorption. One important limiting factor for nasal drug delivery is the limited time available for absorption within the nasal cavity due to mucociliary clearance. Several drug delivery systems including different kinds of microspheres and liposomes have been tried for encapsulation of drugs and increasing the residence time in nasal cavity. In this study the clearance rate of three kinds of liposomes: neutral [phosphatidylcholin (PC) and cholesterol (Chol)], cationic (PC, Chol and stearylamine) and fusogenic (PC, Chol, dioleoylphosphatidylethanolamine) was determined by gamma scintigraphy with lactose powder being used as negative control.

Liposomes were prepared by dehydration-rehydration method. 99mTc labeled liposomes were prepared using technetium pertechnetate in the presence of a potent reducing agent, stannus chloride. The labeling procedure was set in a manner that each 150 µl of liposome suspensions contained 2 MBq of radioactivity. Labeling efficiency was calculated by paper chromatography using acetone as mobile phase. Each delivery system containing 2 MBq of activity was sprayed into right nostril of four healthy volunteers and one-minute static views were repeated each half hour until 4 hours. Clearance rates were compared using two Regions of Interest (ROIs); the initial site of deposition of particles, and all of nasopharynx region. The clearance rate of each one of liposomes was calculated after applying the physical decay corrections.

The mean labeling efficiencies for neutral, cationic and fusogenic liposomes were calculated as 91%, 20% and 69%, respectively. The cleared percent of preparations from nasopharynx region after 4 hours was determined as follows: neutral liposomes 18±2.9%; fusogenic liposomes 53.5±1.2%; cationic liposomes 69.7±4.2%; lactose powder 74.5±4.9%. Neutral liposomes showed the lowest clearance rate compared to lactose powder (P<0.0001), followed by fusogenic liposomes (P<0.01) and cationic liposomes (P<0.05). The clearance profiles of formulations from deposition ROI and nasopharynx ROI were identical.

This study shows the neutral liposomes have the highest mucoadhesion properties and are suitable nasal delivery systems. Furthermore, this study proves that limiting step for the nasal clearance of nasally administered particulate systems is their dislocation from the initial site of deposition, and their following interactions with mucus layer in the rest of nasal passage does not significantly affect the clearance time.

Highlights

Copyright

© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Oct
2015
Nano Liposomes Labeled with 99mTc-HMPAO, a Novel Agent for Blood Pool Imaging

Nano Liposomes Labeled with 99mTc-HMPAO, a Novel Agent for Blood Pool Imaging

Kayvan Sadri,
Salimeh Momenypoor,
Vahid Reza Dabbagh Kakhki,
Ramin Sadeghi,
Kamran Aryana,
Fariba Johari Daha
,et al.

Sadri K, Momenypoor S, Dabbagh Kakhki VR, Sadeghi R, Aryana K, et al. Nano Liposomes Labeled with 99mTc-HMPAO, a Novel Agent for Blood Pool Imaging. Iran J Pharm Res. 2015;14(4):e125385. doi: https://doi.org/10.22037/ijpr.2015.1741

20
Feb
2015
Formulation and Evaluation of Liposomes for Transdermal Delivery of Celecoxib

Formulation and Evaluation of Liposomes for Transdermal Delivery of Celecoxib

Eskandar Moghimipour,
Anayatollah Salami,
Mahsa Monjezi

Moghimipour E, Salami A, Monjezi M. Formulation and Evaluation of Liposomes for Transdermal Delivery of Celecoxib. Jundishapur J Nat Pharm Prod. 2015;10(1):e17653. doi: https://doi.org/10.17795/jjnpp-17653

30
Apr
2012
Freeze-dried Xanthan/Guar Gum Nasal Inserts for the Delivery of Metoclopramide Hydrochloride

Freeze-dried Xanthan/Guar Gum Nasal Inserts for the Delivery of Metoclopramide Hydrochloride

Mohamed Hassan Dehghan,
Mohan Girase

Dehghan MH, Girase M. Freeze-dried Xanthan/Guar Gum Nasal Inserts for the Delivery of Metoclopramide Hydrochloride. Iran J Pharm Res. 2012;11(2):e125844. doi: https://doi.org/10.22037/ijpr.2012.1088

31
Oct
2018
Biodistribution of Tc-99m Labeled Isoniazid Solid Lipid Nanoparticles in Wistar Rats

Biodistribution of Tc-99m Labeled Isoniazid Solid Lipid Nanoparticles in Wistar Rats

Fereshteh Ghazizadeh,
Solmaz Ghaffari,
Seyedeh Fatemeh Mirshojaei,
Mohammad Mazidid,
Shirzad Azarmi

Ghazizadeh F, Ghaffari S, Mirshojaei SF, Mazidid M, Azarmi S. Biodistribution of Tc-99m Labeled Isoniazid Solid Lipid Nanoparticles in Wistar Rats. Iran J Pharm Res. 2018;17(4):e124860. doi: https://doi.org/10.22037/ijpr.2018.2301

28
Feb
2014
Preparation and Characterization of Stable Nanoliposomal Formulation of Fluoxetine as a Potential Adjuvant Therapy for Drug-Resistant Tumors

Preparation and Characterization of Stable Nanoliposomal Formulation of Fluoxetine as a Potential Adjuvant Therapy for Drug-Resistant Tumors

Azadeh Haeri,
Behdokht Alinaghian,
Marjan Daeihamed,
Simin Dadashzadeh

Haeri A, Alinaghian B, Daeihamed M, Dadashzadeh S. Preparation and Characterization of Stable Nanoliposomal Formulation of Fluoxetine as a Potential Adjuvant Therapy for Drug-Resistant Tumors. Iran J Pharm Res. 2014;13(Suppl):e125473. doi: https://doi.org/10.22037/ijpr.2014.1453

More by these authors

Mahmoud Reza JaafariPubMedScholar
Mohsen TafaghodiPubMedScholar
Sayyed Abolghassem Sajadi TabassiPubMedScholar
Share
Cited by
Metrics